Pharmacological manipulation of Sema4D by salvianolic acid A mitigates diabetic retinopathy via inhibiting PlexinB1/RhoA/ROCK/pMLC2 signaling cascade involved in endothelial dysfunction

Abstract Background Diabetic retinopathy (DR) is a leading cause of blindness. While anti-vascular endothelial growth factor (VEGF) therapy is effective, its utility is limited by variable patient response and the need for frequent injections. Therefore, identifying new therapeutic targets for DR is...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Weiwei Zheng, Ling Ning, Peiliang Shen, Jing Ma, Chang Yu, Ruiqin Jia, Liwenyu Chen, Wei Zou, Yuhua Xu, Yanhong Pan, Zhonghong Wei, Qiuhong Shen, Chongjin Zhong, Aiyun Wang, Wenxing Chen, Juan Chen, Suyun Yu, Jia Li, Yin Lu, Yang Zhao
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	BMC 2026-07-01
סדרה:	Chinese Medicine
נושאים:	Salvianolic acid A Diabetic retinopathy Sema4D Astrocytes Endothelial junctions Liposomes
גישה מקוונת:	https://doi.org/10.1186/s13020-026-01468-z
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!